ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 173 filers reported holding ICU MED INC in Q3 2014. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,996,340 | +34.7% | 311,542 | +21.7% | 0.01% | +42.9% |
Q1 2024 | $27,468,985 | +24.8% | 255,954 | +16.0% | 0.01% | +16.7% |
Q4 2023 | $22,005,190 | -12.5% | 220,624 | +4.3% | 0.01% | -25.0% |
Q3 2023 | $25,162,211 | +116.9% | 211,428 | +224.8% | 0.01% | +100.0% |
Q2 2023 | $11,598,935 | +232.7% | 65,098 | +208.0% | 0.00% | +300.0% |
Q1 2023 | $3,486,760 | +48394.6% | 21,137 | -53.7% | 0.00% | -50.0% |
Q4 2022 | $7,190 | -100.0% | 45,658 | -57.8% | 0.00% | -66.7% |
Q3 2022 | $16,291,000 | -64.6% | 108,168 | -61.3% | 0.01% | -64.7% |
Q2 2022 | $46,004,000 | -39.7% | 279,829 | -18.3% | 0.02% | -26.1% |
Q1 2022 | $76,248,000 | -4.4% | 342,453 | +2.0% | 0.02% | -4.2% |
Q4 2021 | $79,722,000 | +3.0% | 335,891 | +1.2% | 0.02% | -4.0% |
Q3 2021 | $77,435,000 | +18.3% | 331,784 | +4.3% | 0.02% | +19.0% |
Q2 2021 | $65,464,000 | +19.9% | 318,099 | +19.5% | 0.02% | +16.7% |
Q1 2021 | $54,579,000 | +3.1% | 266,197 | +7.8% | 0.02% | -5.3% |
Q4 2020 | $52,962,000 | +18.5% | 246,923 | +1.0% | 0.02% | 0.0% |
Q3 2020 | $44,686,000 | +1.3% | 244,507 | +2.1% | 0.02% | 0.0% |
Q2 2020 | $44,116,000 | -8.3% | 239,382 | +0.4% | 0.02% | -24.0% |
Q1 2020 | $48,125,000 | +16.9% | 238,544 | +8.4% | 0.02% | +66.7% |
Q4 2019 | $41,180,000 | +32.0% | 220,082 | +12.6% | 0.02% | +25.0% |
Q3 2019 | $31,197,000 | -17.2% | 195,487 | +30.7% | 0.01% | -20.0% |
Q2 2019 | $37,668,000 | +8.1% | 149,539 | +2.7% | 0.02% | +7.1% |
Q1 2019 | $34,842,000 | +2.7% | 145,586 | -1.5% | 0.01% | -6.7% |
Q4 2018 | $33,940,000 | -22.6% | 147,812 | -4.7% | 0.02% | -11.8% |
Q3 2018 | $43,841,000 | -35.0% | 155,057 | -32.5% | 0.02% | -37.0% |
Q2 2018 | $67,481,000 | -15.0% | 229,802 | -26.9% | 0.03% | -18.2% |
Q1 2018 | $79,353,000 | +11.6% | 314,392 | -4.5% | 0.03% | +13.8% |
Q4 2017 | $71,115,000 | +9.4% | 329,234 | -5.9% | 0.03% | +3.6% |
Q3 2017 | $64,996,000 | -4.8% | 349,725 | -11.6% | 0.03% | -12.5% |
Q2 2017 | $68,282,000 | +8.7% | 395,836 | -3.8% | 0.03% | +6.7% |
Q1 2017 | $62,828,000 | -16.9% | 411,445 | -19.8% | 0.03% | -21.1% |
Q4 2016 | $75,632,000 | +7.9% | 513,286 | -7.4% | 0.04% | 0.0% |
Q3 2016 | $70,071,000 | +5.2% | 554,453 | -6.2% | 0.04% | 0.0% |
Q2 2016 | $66,612,000 | +3.4% | 590,804 | -4.6% | 0.04% | -2.6% |
Q1 2016 | $64,448,000 | -11.7% | 619,094 | -4.3% | 0.04% | -13.3% |
Q4 2015 | $72,975,000 | +6.6% | 647,060 | +3.5% | 0.04% | 0.0% |
Q3 2015 | $68,484,000 | +17.0% | 625,431 | +2.2% | 0.04% | +25.0% |
Q2 2015 | $58,516,000 | +5.9% | 611,712 | +3.1% | 0.04% | +2.9% |
Q1 2015 | $55,270,000 | +28.1% | 593,426 | +12.7% | 0.04% | +25.0% |
Q4 2014 | $43,144,000 | +37.0% | 526,775 | +7.3% | 0.03% | +27.3% |
Q3 2014 | $31,496,000 | +5.4% | 490,727 | -0.1% | 0.02% | +4.8% |
Q2 2014 | $29,878,000 | +15.4% | 491,330 | +13.6% | 0.02% | +10.5% |
Q1 2014 | $25,887,000 | -5.1% | 432,326 | +0.9% | 0.02% | -9.5% |
Q4 2013 | $27,291,000 | -2.3% | 428,354 | +4.2% | 0.02% | -12.5% |
Q3 2013 | $27,932,000 | +0.7% | 411,194 | +6.9% | 0.02% | -7.7% |
Q2 2013 | $27,726,000 | – | 384,756 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |